Related Experiment Video
Updated: Apr 18, 2026
06:07
Direct Bioprinting of 3D Multicellular Breast Spheroids onto Endothelial Networks
Published on: November 2, 2020
5.5K
β1 and β4 integrins: from breast development to clinical practice
Paola Nisticò1, Francesca Di Modugno, Sheila Spada
1Laboratory of Immunology, Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, 00144, Italy. nistico@ifo.it
Breast Cancer Research : BCR
|January 22, 2015
Summary
Integrins, crucial for breast development and function, regulate cell interactions with the extracellular matrix. Dysregulation of beta1 and beta4 integrins is implicated in breast cancer, highlighting their potential as therapeutic targets.
Area of Science:
- Cell Biology
- Developmental Biology
- Oncology
Background:
- Mammary gland development involves complex epithelial-microenvironment interactions throughout reproductive cycles.
- Extracellular matrix (ECM) receptors, particularly integrins, mediate cell-ECM and cell-cell communication, crucial for tissue architecture and function.
- Imbalances in ECM-integrin signaling pathways can contribute to oncogenesis.
Purpose of the Study:
- To review the role of beta1 and beta4 integrins in normal breast differentiation.
- To explore the cross-talk between beta1 and beta4 integrins and tyrosine kinase receptors.
- To discuss the potential of these integrin subunits as prognostic and therapeutic targets in breast cancer.
Main Methods:
- Literature review focusing on integrin signaling in mammary gland biology.
- Analysis of the interplay between integrins and tyrosine kinase receptors.
- Examination of the clinical relevance of integrin subunits in breast cancer.
Main Results:
- Beta1 and beta4 integrins are key mediators of cell-ECM interactions essential for mammary gland development and differentiation.
- Integrin signaling pathways are intricately linked with tyrosine kinase receptor pathways.
- Aberrant integrin expression and function are associated with breast cancer progression and patient outcomes.
Conclusions:
- Beta1 and beta4 integrins play critical roles in normal breast development and differentiation.
- Targeting the ECM-integrin axis, specifically beta1 and beta4 integrins, presents a promising strategy for breast cancer therapy.
- Further research into integrin-tyrosine kinase receptor interactions may yield novel prognostic and therapeutic approaches for breast cancer.
Related Concept Videos
01:15Activation of Integrins
5.7K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.7K
01:17Intracellular Signaling Affects Focal Adhesions
3.9K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.9K
01:10Integrins
6.2K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
6.2K
01:25Selectins
4.9K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
4.9K
01:25Fibronectins Connect Cells with ECM
3.8K
Fibronectin is an adhesive glycoprotein present in the extracellular matrix of embryogenic and adult tissue. These molecules primarily aid in regulating cell motility and attachment. A fibronectin molecule is composed of two identical polypeptide chains attached to each other by a pair of disulfide bonds at the C-terminal.
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
3.8K
01:31Immunoglobulin-like Cell Adhesion Molecules
4.7K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
4.7K